Landmark findings from a major malaria clinical trial led by Menzies School of Health Research (Menzies) and international ...
On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended ...
Other than recrudescence within the pharmacologically active period after chloroquine treatment, the rate of vivax relapse following treatment reflects responsiveness to primaquine. A rate of 20 to 30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results